Literature DB >> 27779082

Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs.

Inmaculada Dona1, Maria Salas, James R Perkins, Esther Barrionuevo, Francesco Gaeta, Jose A Cornejo-Garcia, Paloma Campo, Maria Jose Torres.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the leading causes of hypersensitivity reactions to drugs, and they are classified in two groups: those induced by nonspecific immunological mechanisms (non-allergic or cross-intolerance (CI) reactions), or by specific immunological mechanisms (allergic or selective reactions (SR)). The pathogenesis of CI is associated with their pharmacological activity (COX-1 inhibition), with symptoms due to an imbalance in the arachidonic acid pathway, independently of their chemical structure. SRs are mediated by specific IgE- or by a T-cell response and can be induced by a single NSAID or a class of chemically related NSAIDs, with patients tolerating chemically unrelated compounds. NSAIDs hypersensitivity reactions have been classified in five main groups: i) NSAIDs-exacerbated respiratory disease (NERD); ii) NSAIDs-exacerbated cutaneous disease (NECD); iii) NSAIDs-induced urticaria/angioedema (NIUA); iv) Single NSAID-induced urticaria/angioedema or anaphylaxis (SNIUAA); v) Single NSAID-induced delayed reactions (SNIDRs). Although this classification described above is widely accepted by most authors some phenotypes such as blended reactions do not fit. Therefore more research is needed in this topic. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  IgE; Non-steroidal anti-inflammatory drugs; T-cell response; blended reactions.; classification; cross-intolerance; hypersensitivity reactions; selective reactions

Mesh:

Substances:

Year:  2016        PMID: 27779082     DOI: 10.2174/1381612822666160928142814

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

Review 1.  Anaphylaxis.

Authors:  Daniel LoVerde; Onyinye I Iweala; Ariana Eginli; Guha Krishnaswamy
Journal:  Chest       Date:  2017-08-08       Impact factor: 9.410

2.  Exploring targets and signaling pathways of paeonol involved in relieving inflammation based on modern technology.

Authors:  Jian-Hong Qi; Fang-Xu Dong; Xiao-Long Wang
Journal:  Mol Divers       Date:  2021-08-31       Impact factor: 3.364

3.  Vindoline Attenuates Osteoarthritis Progression Through Suppressing the NF-κB and ERK Pathways in Both Chondrocytes and Subchondral Osteoclasts.

Authors:  Meisong Zhu; Qiang Xu; Xinmin Yang; Haibo Zhan; Bin Zhang; Xuqiang Liu; Min Dai
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

Review 4.  NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation.

Authors:  Zhilei Wang; Guang Xu; Zhiyong Li; Xiaohe Xiao; Jianyuan Tang; Zhaofang Bai
Journal:  J Inflamm Res       Date:  2022-01-19

5.  Analysis of Clinical Features of Non-steroidal Anti-inflammatory Drugs Induced Kounis Syndrome.

Authors:  Chunjiang Wang; Weijin Fang; Liying Song; Zhenzhen Deng; Zuojun Li; Linli Sun
Journal:  Front Cardiovasc Med       Date:  2022-07-11

6.  Mechanism of Anti-Inflammatory and Antibacterial Effects of QingXiaoWuWei Decoction Based on Network Pharmacology, Molecular Docking and In Vitro Experiments.

Authors:  Qian Zhang; Xue Li; Jun Li; Yuxia Hu; Jing Liu; Fang Wang; Wei Zhang; Fuhou Chang
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

Review 7.  Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System.

Authors:  Cristina Monteiro; Samuel Silvestre; Ana Paula Duarte; Gilberto Alves
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.